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This study aims to evaluate the feasibility, acceptability and preliminary efficacy of an 
Australian-adapted Substance Use Treatment Programme (SUTP) among mentally ill 
offenders in an Australian secure forensic setting. A single-group non-controlled pilot trial 
was conducted. Four SUTP treatment groups were run simultaneously (n=39) with sessions 
held weekly over 12 weeks. Feasibility was assessed by examining attrition, study retention 
and motivation for treatment, and measures of therapeutic alliance, client satisfaction and 
qualitative interviews were used to determine acceptability. Preliminary efficacy was 
assessed using self-report questionnaires implemented at baseline and post-intervention 
measuring drug related locus of control, confidence to resist substances in the future and 
beliefs about substance use. Low attrition, high levels of satisfaction and moderately positive 
levels of therapeutic alliance were found. Participants also demonstrated a significant shift 
towards an internal drug related locus of control upon completion of SUTP. SUTP is a 
promising intervention for mentally ill offenders with a history of substance use in Australian 
forensic services. A randomised controlled trial is warranted to rigorously evaluate the 
efficacy of SUTP in this setting.  
 








Mental disorders occur at high rates among prisoners worldwide (Fazel, 2012). In 
Australia, rates of mental disorders among these individuals are disproportionately high when 
compared with the general population. The 12-month prevalence of any mental disorder in 
prisoners is 46%, far exceeding that of a matched sample of the Australian general population 
(16%), indicating that prisoners are nearly five times more likely to have a mental disorder 
when compared with the community (OR=4.7, 95% CI=4.0-5.6; Butler, Andrews, Allnutt, 
Sakashita, Smith, & Basson, 2006). A common point at which Australian prisoners are 
identified as having a mental disorder is during the course of a special hearing or trial where 
an individual can be found ‘Not Guilty by Reason of Mental Illness’ by a judge or jury. This 
is determined when the person is found not to have the requisite responsibility to be found 
guilty of the crime because of their mental illness (Boyd-Caine & Chappell, 2005). In New 
South Wales (NSW), the most populous state in Australia, 364 individuals were found not 
guilty by reason of mental illness between 1990 and 2010 (Hayes, Kemp, Large, & Nielssen, 
2014). A more recent survey of forensic inpatients in NSW reported that the most common 
diagnosis among people who are found not guilty by reason of mental illness is a psychotic 
disorder, with a prevalence of 83% (Justice Health and Forensic Mental Health Network; 
JHFMHN, 2016). Other mental disorders in this group included personality disorders (13%), 
depression (13%), and neurocognitive disorders (11%). The study reported that the most 
common unlawful act committed by NSW forensic patients was murder (41%), followed by 
assault resulting in serious injury (16%), aggravated sexual assault (15%), aggravated 
robbery (8%) and attempted murder (6%; JHFMHN, 2016). These patients are placed under 
the supervision of the Mental Health Review Tribunal and are treated in a secure hospital 
setting by NSW Health until they are deemed well enough to be granted conditional release 





Rates of substance use disorders in prisoners are also extremely high (Fazel, Bains, & 
Doll, 2006), with between half to two-thirds (55%-66%) of Australian adult prisoners 
diagnosed with a substance use disorder in the past 12 months; a rate that is 11 times higher 
than adults in the general population (Butler et al., 2006; Butler, Indig, Allnutt, & Mamoon, 
2011). Furthermore, empirical evidence among both national and international samples has 
demonstrated that mentally ill offenders, in particular, experience high rates of co-occurring 
substance use disorders (Butler et al., 2011; Ogloff, Lemphers, & Dwyer, 2004; Scott, 
Whyte, Burnett, Hawley, & Maden, 2004; Tyler, Miles, Karadag, & Rogers, 2019; Wright, 
Walters, & Strang, 2016). A 2018 study of mentally ill patients the NSW secure forensic 
hospital reported that three-quarters of patients (75%) had a diagnosed substance use disorder 
(Eagle, Ma, & Sinclair, 2019). This of significant importance, given that individuals with co-
occurring mental illness and substance use disorders present with a much more complex 
clinical profile and an increased risk for reoffending (Barrett, Teesson, & Mills, 2014; Baxter, 
Rabe-Hesketh, & Parrott, 1999; De Burca, Miles, & Vasquez, 2013), with previous research 
demonstrating an association between the use of alcohol and drugs and the reconviction of 
released forensic patients (Scott et al., 2004; Smith & Trimboli, 2010). There is a critical 
need to identify and address co-occurring substance use disorders in mentally ill offenders, 
not only to improve clinical outcomes for this population, but to significantly reduce risk of 
reoffending in the community (Pickard & Fazel, 2013).  
Despite the high prevalence and harms associated with substance use disorders 
among mentally ill offenders (Clarke, Davies, Hollin, & Duggan, 2011; Johnson, Smith, 
Crowe, & Donovan, 1993), there continues to be a paucity of research examining effective 
treatment approaches for this population. Psychoeducation tends to be the predominant model 
of care for mentally ill offenders with a substance misuse history, despite previous research 





(Sandbrook, Clark, & Cocksedge, 2015). In contrast, research strongly supports the use of 
cognitive behavioural therapy (CBT) as a treatment for substance use disorders in both 
individual and group settings (Jhanjee, 2014; McHugh, Hearon, & Otto, 2010). Moreover, 
international guidelines recommend the use of CBT in the treatment of substance use 
disorders (National Institute of Health and Care Excellence, 2007) and a number of meta-
analyses report the positive effects of CBT on the recidivism of offenders (Landenberger & 
Lipsey, 2005; Lipsey, Chapman, & Landenberger, 2001; Mpofu, Athanasou, Rafe, & 
Belshaw, 2018). 
There is a critical need for further evaluation of CBT-based approaches for addressing 
substance use disorders in mentally ill offenders in Australia. Emerging research conducted 
in medium secure settings in the United Kingdom (UK) has demonstrated promising results. 
One study found that 16 weekly group sessions of a CBT-based programme for substance use 
(n=37) improved external motivation for treatment compared to those who completed a 
psychoeducation-based intervention (n=43), however, both groups experienced high drop-out 
rates of 46% and 29%, respectively (Tibber, Piek, & Boulter, 2015). Another CBT-based 
programme comprised of 16 weekly group sessions plus 5 individual sessions delivered to 23 
patients in a medium secure unit demonstrated a statistically significant pre to post-
intervention increase in inpatient’s confidence to resist their drug of choice (Oddie & Davies, 
2009). This program also proved to be highly acceptable to participants, as evidenced by high 
attendance and positive feedback in qualitative interviews at post-intervention (Oddie & 
Davies, 2009). A similar 10 session group programme was implemented in East London, 
with no formal evaluation completed (Wood, Patel, Skinner, & Thomson, 2009). However, 
qualitative feedback from key professional staff involved in service provision indicated that it 





understand the impact that substance use can have on individuals, which has clear benefits for 
themselves and their clients (Wood et al., 2009). 
High secure forensic settings have also demonstrated promising findings for the 
efficacy of using a CBT-based treatment approaches for substance use disorders in the UK. 
An evaluation of a weekly substance use group treatment programme delivered to 30 male 
patients in Wales over a 9- to 14-month period found a significant pre-post assessment 
change in patient reported ambivalence, which was interpreted as an acknowledgement of the 
problematic nature of substance misuse (Morris & Moore, 2009). Another high secure study 
in Scotland involved an evaluation of a coping and social skills relapse prevention group 
programme (28 three-hour sessions over a 14-week period) delivered to 83 male participants 
(Ritchie, Weldon, Freeman, MacPherson, & Davies, 2011). Those who completed the 
programme showed a significant post-intervention increase in confidence to resist their 
primary substance of choice in the future. Although the programme focused primarily on 
social skills, it demonstrated the beneficial changes that dual diagnosis targeted interventions 
can achieve.  
One of the most promising CBT-based programmes for forensic patients is the 
Substance Use Treatment Programme (SUTP; Miles, 2015). An earlier version of this 
programme containing 24 one-hour, group sessions delivered weekly in a medium secure 
forensic setting was evaluated with 19 participants in the UK (Miles, Dutheil, Welsby, & 
Haider, 2007). In this study, SUTP was found to significantly increase abstinence rates, with 
74% (n=14) remaining abstinent at the end of the programme. The authors acknowledge that 
the high rates of abstinence could be due to both legal restrictions and incentives, such as day 
leave, contributing to increased motivation (Miles et al., 2007). Derry and Batson (2008) also 
conducted a preliminary analysis into the effectiveness of this 24-session version of SUTP in 





completed SUTP (defined as attending at least 18 out of 24 weekly sessions) were 
significantly less likely to use drugs or alcohol after discharge (50% had used drugs), 
compared to those who did not complete it (74% had used drugs). Additionally, the SUTP 
participants spent a significantly greater proportion of time in the community following 
discharge (89%), compared to those who didn’t receive the treatment (77%). The SUTP was 
refined and modified to consist of 12 two-hour, group sessions delivered weekly to medium 
secure forensic patents (Miles, 2015). Due to the restrictive environment, the study did not 
focus on abstinence rates but rather on measured cognitive change such as participants 
adaptive beliefs around substance use and cravings. Significant pre- to post-treatment 
improvements were found, as well as high satisfaction levels with the programme (Miles, 
2015).  
These promising findings of the SUTP make it a relevant programme to address the 
gaps in practice in Australian forensic secure services. There is a critical need for evidence-
based treatment approaches for offenders with mental health and drug and alcohol 
comorbidity. An evaluation of SUTP outside of the UK will determine its generalisability to 
participants in Australia. Additionally, the SUTP has been tested predominantly in medium 
secure settings, leaving a need for further evaluation in a high secure setting. As such, this 
study aims to evaluate the feasibility, acceptability and preliminary efficacy of the SUTP 
among forensic inpatients in an Australian high secure forensic hospital. This is the first 
study to evaluate the CBT-based SUTP among mentally ill offenders in Australia, which will 
directly inform clinical practice and contribute significantly to global knowledge in this area. 
Method 
Design and setting 
The current study involves a single-group non-controlled pilot trial, conducted in a 





mentally ill patients aged 18 years and over who have been in contact with the criminal 
justice system, as well as high-risk civil patients. Ethical approval for this study was granted 
by the JHFMHN Human Research Ethics Committee (2019/ETH00244) and the Aboriginal 
Health and Medical Research Council of NSW Human Research Ethics Committee 
(AHMRC: 1533/19). Site Specific approval was also granted by the JHFMHN 
(2019/STE00375). The pilot study was conducted from September 2019 to December 2019, 
during which time participants were recruited, received the SUTP and completed pre- and 
post-intervention assessments.  
Participants and procedure 
All participants (N=39) were inpatients of the forensic hospital who had been 
identified by their multi-disciplinary treating teams as requiring a substance misuse 
intervention and subsequently referred to the SUTP. Patients were informed of the pilot study 
by their treating team, after which they were given the opportunity to participate. Informed 
written consent was obtained from all interested participants by a researcher-clinician who 
was independent of the clinical care of the patient. Reassurance was provided that a patient’s 
decision whether or not to participate in the research study would not impact the care or 
treatment provided at the hospital. An Aboriginal mental health professional was present 
during the attainment of informed consent from all patients who identified as being of 
Aboriginal and Torres Strait Islander descent to ensure that historical factors did not 
influence the participants consent to partake in the research. Patients who did not wish to take 
part in the study, or who were not well enough to provide consent (as assessed by their 
treating team), were still offered to take part in the programme as part of their routine clinical 






All referred patients who were interested in being involved in the research were 
assessed for eligibility using a screening tool designed for the purposes of this study. 
Participants were included if they were aged over 18 years and experienced harmful or 
hazardous alcohol use (as assessed by the Alcohol Use Disorders Identification Test 
[AUDIT] >=8; Babor, Higgins-Biddle. Saunders & Monteiro, 2001) or drug use (as 
determined by the Drug Use Disorders Identification Test [DUDIT] >=6 for males, >=2 for 
females; Berman, 2003). The AUDIT and DUDIT items were asked in relation to the year 
prior to incarceration. Participants were excluded if they had a severe cognitive impairment 
or if they were too unwell to receive the programme (as determined by their treating team), 
had difficulty speaking or comprehending English, or if they were unable to provide 
informed consent. Of the 52 patients who were referred for inclusion in the pilot SUTP, 39 
were deemed eligible to be included and provided consent. Of those who were excluded, 10 
patients declined to participate (nine refused the treatment and one declined to participate in 
the study), two were too unwell at the time of the treatment being offered, and one had been 
discharged prior to group commencement (see Figure I).  
[INSERT FIGURE I ABOUT HERE] 
Eligible participants were allocated to one of four concurrent SUTP groups (described 
below) and completed face-to-face assessments at baseline (i.e., pre-intervention) and 3-
months post-baseline (i.e., post-intervention). Baseline and post-intervention follow up 
assessments were administered by a researcher-clinician independent of the treating team and 
took approximately 45 minutes and 25 minutes to complete, respectively. Thirty-three 
participants (84.6%) participated in the post-intervention assessments and qualitative 
interviews. Participants who dropped out during the first session (n=3), were discharged from 
the hospital (n=2), or refused to complete the follow-up assessment (n=1) were considered 





participants completed all acceptability and efficacy measures and three participants 
completed the acceptability measures only (total sample size for the CSQ-8 at post-














Figure I: Study flow diagram for the SUTP  
 
Assessed for eligibility (n=52) 
Excluded (n=13) 
- Declined to participate (n=10) 
- Mental health deterioration (n=2) 
- Discharged prior to programme 
commencement (n=1) 
 
Lost to follow-up (n=6) 
– Dropped out after first session and did 
not complete any of the post 
intervention assessment (n=3) 
– Discharged from hospital (n=2) 
– Refused to complete post intervention 
assessment (n=1) 
Allocated to intervention (n=39) 
Analysed (n=33) Analysis 
Follow-Up 







The Substance Use Treatment Programme (SUTP) 
The SUTP comprises two stages containing six sessions in each stage. Table I 
outlines the contents of each of the stages and sessions. The programme was developed 
within a CBT framework and is underpinned by motivational interviewing (Miles, 2015). The 
SUTP typically contains a “New Horizon” group which are participant lead booster sessions, 
however, for the purposes of this pilot study, booster sessions were not offered. Participants 
were assigned to one of four concurrent groups of SUTP, each of which ran weekly sessions 
for 12 weeks and were facilitated by two Forensic Hospital Allied Health Professionals, per 
group. There was a maximum of 10 patients in each SUTP group at one time. Staff from the 
Forensic Hospital Allied Health team were trained in the delivery of the treatment 
programme by developer Dr Helen Miles via a two-day, face-to-face workshop.  
 


















Substance use treatment programme (SUTP) session plan outline 
Stage 1  
Week 1 Group introductions and building engagement – Opening discussions, using socratic 
questioning and substance use (e.g. role in society, participants lifestyle prior to 
hospital etc.) 
Week 2 Building motivation for change – Motivational interviewing exercises (e.g. evaluation 
of the pros/cons of substance use, using a decisional balance process), identification of 
the negative effects of substance on different areas of life, goal setting to improve 
identified problem areas and formulation of personal motivational statements for 
abstinence 
Week 3 Alcohol – Psychoeducation on the effects of alcohol, harm minimisation (e.g. alcohol 
units and safe limits quiz), role of alcohol on medication. Visual “pig liver” 
demonstration, to demonstrate the impacts of alcohol on the liver. 
Week 4  Cannabis – Psychoeducation on the effects of cannabis particularly on mental health 
and relapse, links to personal experiences and multi-media props (video/newspaper)  
Week 5  Other substances – Psychoeducation on the effects of other illicit substances (e.g. 
stimulants, hallucinogens, solvents and opiates), linking these substances to mental 
illness and offending behaviour 
Week 6 Substance use and offending behaviour – Examination of direct and indirect links 
between substance use and crimes/own offending behaviours (e.g. timeline reviews).  
Stage 2  
Week 7  Self-esteem – Creative activity to explore participants view of self without substances 
and increases their self-esteem  
Week 8 Functional analysis of substance use – CBT exercises (e.g. ABC charts exploring past 
substance use) to explore the function/reason for past use, identification of future high-
risk situations/triggers for use, alternative coping strategies/activities and problem 
solve any barriers to change.  
Week 9 Assertiveness – Identification of different communication styles and improvement of 
assertive refusal skills through role play exercises, identification of appropriate social 
support networks  
Week 10 Craving – Identification of craving and “urge surfing” strategies (e.g. cue cards), and 
management of negative feelings (e.g. relaxation exercises) 
Week 11 “Set ups” and lapses – Identification of risks for relapse and exploration of 
recommitting to abstinence after a lapse (e.g. challenging negative thinking, role-
plays) 
Week 12  Relapse prevention plan – Review the past 11 weeks and development of an individual 





Adaptation of SUTP for the Australian setting 
Seven experts were consulted to adapt the content of the SUTP manual for forensic 
patients in the Australian setting. Experts included individuals with a lived experience of 
mental illness, current peer workers and past patients of the hospital, as well as staff who 
work closely with family and carers who represented their views on treatment programmes. 
Additionally, an Aboriginal health worker and Aboriginal peer worker consulted on the 
manual to advise on any cultural considerations or changes that would be needed. Based on 
the feedback obtained, amendments were made to the content, in particular the vignettes and 
language. All other aspects of the programme remained the same including the length, 
number and structure of sessions as well as the key therapeutic techniques.    
Measures  
Measures used to assess feasibility, acceptability and preliminary efficacy are 
described in detail in Table II and summarised below. 
[INSERT TABLE II ABOUT HERE] 
Feasibility 
Treatment adherence was measured by attendance at each of the 12 SUTP sessions 
and study retention was assessed according to the follow-up rate at post-intervention. To 
assess motivation and reasons for entering treatment, the 9-item Treatment Entry 
Questionnaire (TEQ; Urbanoski & Wild, 2012) was administered at baseline. As described in 
Table II, the TEQ includes three subscales regarding the motivation for entering treatment, 
including ‘identified’, ‘introjected’ and ‘external’ motivation. Total scores for each subscale 
range from 3 to 21, with higher scores on each subscale indicating higher levels of identified, 







Participant satisfaction with the SUTP was measured at post-intervention using the 8-
item self-report Client Satisfaction Questionnaire (CSQ-8; Attkisson & Greenfield, 1996). 
Total scores range from 8 to 32, with higher scores indicating higher levels of satisfaction 
with the programme. Participants were also asked six open-ended questions on their 
experience of the treatment programme, including what aspects they found most and least 
helpful, what elements they would change, what impact the program has had on their life, and 
whether they had experienced similar treatment programmes in the past.  
Therapeutic alliance was measured using the 12-item Working Alliance Inventory-
Short Form (Horvath, 1991). Total scores range from 12 to 84 with higher scores being 
indicative of a more positive therapeutic alliance and improved client outcomes (Sturgiss, 
Rieger, Haesler, Ridd, Douglas, & Galvin, 2019).  
Preliminary efficacy 
Participants were invited to take part in a face-to-face, structured baseline assessment 
that collected information on demographic characteristics (e.g., date of birth, gender, country 
of birth), drug use history, treatment history, confidence to resist substance use in the future, 
drug related locus of control, multi-dimensional locus of control and beliefs about substance 
use (the validated measures used to assess these constructs are discussed below and described 
in detail in Table II). At post-intervention, participants were invited to take part in an 
assessment that re-assessed confidence to resist substance use, drug related locus of control, 
multi-dimensional locus of control, and beliefs about substance use. It was not possible to 





forensic hospital. Participant attitudes and beliefs towards substance use were measured to 
provide insight into future substance related behaviours.  
To assess level of confidence in being able to cope with high-risk situations with 
respect to their previous addictive behaviours, participants were administered the 8-item 
Drug Taking Confidence Questionnaire (DTCQ-8;Sklar & Turner, 1999). Scores on the 
DTCQ range from 0 to 100, whereby higher scores are indicative of greater confidence to 
resist urges to use substances.  
Locus of control was measured by 15-item Drug Related Locus of Control (DR-LOC; 
Ersche, Turton, Croudace, & Stochl, 2012) and 24-item Levenson Multi-Dimensional Locus 
of Control Questionnaire (MD-LOC; Levenson, 1973). DR-LOC assesses the extent to which 
a person believes that the outcome of 15 specific drug-related events are under their personal 
control (i.e., internal locus of control) or the influence of external circumstances (i.e., external 
locus of control). Scores range from 0 to 15; higher scores indicate a stronger belief of 
external locus of control. Levenson MD-LOC (Levenson, 1973) consists of three subscales 
addressing different beliefs about locus of control: internal (control over own life), powerful 
others (other’s control over one’s life) and chance (life is a matter of chance). A higher rating 
on internal locus of control subscale (MD-LOC Internal) indicates a strong internal locus of 
control, and high scores on the powerful others (MD-LOC Powerful Others) and chance 
(MD-LOC Chance) subscales indicates a strong external locus of control.  
Beliefs about substance use, such as whether participants believe they need 
substances to cope or fulfil a need, was assessed using a 20-item Beliefs about Substance Use 
(BSU) questionnaire (Beck, Wright, Newman, & Liese, 1993). Total scores range from 20 to 






Table II. Summary of the validated scales used in the current study 




(TEQ; Urbanoski & 
Wild, 2012) 
The 8-item TEQ-9 includes three subscales that include the degree to which the 
person entered treatment because: i) the participant identifies personally with the 
positive value of behaviour change and are committed by personal choice to the 
goals of the treatment programme (i.e., ‘identified’ motivation), ii) the participant 
identifies with what will happen negatively if they do not change such as the impact 
of their own feelings of guilt on themselves (i.e., ‘introjected’ motivation), and iii) 
attendance is due to an external referral, identified pressure, ultimatum or another 
coercive social force (i.e. ‘external’ motivation). Four items assess each of the three 
subscales, rated on a 7-point Likert scale ranging from 1 ‘strongly disagree’ to 7 
‘strongly agree’ (total scores for each subscale range from 3 to 21). A weighted 
mean is calculated for each motivational subscale, with higher scores indicating 
higher levels of identified, introjected, and external motivation of motivation for 
entering treatment. A high score for one type of motivation does not prevent a high 
score for another. 
The TEQ has high internal consistency in a substance 
misuse residential population (internal motivation α=.90, 
introjected motivation α=.83, and external motivation 
α=.87; Urbanoski & Wild, 2012). In the current study, the 
TEQ showed moderate reliability for internal motivation 
(α=.67) and introjected motivation (α=.69) and high 
reliability for external motivation (α=.84). While the 
internal and introjected subscale scores are just below the 
standard threshold of internal reliability (Cronbach’s alpha 
<0.7), it has been argued that a reliability of >.60 is 








The 8 items of the CSQ are scored on a Likert scale from 1 to 4, with 1 indicating 
low satisfaction and 4 high satisfaction. Total scores range from 8 to 32, with higher 
scores indicating higher levels of satisfaction with the programme. Due to the scales 
single factor structure, the results were compared with external data that constitutes 
an appropriate norm (e.g., the multi-service setting means and standard deviation 
results presented in previous studies (Attkisson & Greenfield, 1996; Attkisson & 
Zwick, 1982) 
The CSQ-8 demonstrates high levels of internal consistency 
in mental health settings (Cronbach’s α=0.83-0.93; 
Attkisson & Greenfield, 1996) and residential substance use 
settings (Cronbach’s α=0.92;  Kelly, Kyngdon, Ingram, 
Deane, Baker, & Osborne, 2018). The CSQ-8 was also 
shown to be a reliable measure in the current study, as 






The 12 items on the WAI-SF are rated on a 7-point Likert scale ranging from 1 
‘never’ to 7 ‘always’, with total scores ranging from 12 to 84 (items 4 and 10 are 
reverse coded). Higher scores are indicative of a more positive therapeutic alliance 
and improved client outcomes (Sturgiss et al., 2019) 
The WAI-SF demonstrates high levels of reliability in 
therapeutic settings (Cronbach's α=0.85; Sturgiss et al., 
2019) and  rehabilitation settings (Cronbach's α=0.93; Paap, 
Schrier, & Dijkstra, 2019), and moderate to high levels of 
reliability in forensic mental health rehabilitation settings 





Gibbons, Mohan, & Kennedy, 2011) including in the 





(DTCQ-8; Sklar & 
Turner, 1999) 
The 8-item DTCQ-8 identifies eight future high-risk situations: unpleasant 
emotions, physical discomfort, pleasant emotions, testing personal control, urges 
and temptation to use, conflict with others, social pressure to use, and pleasant times 
with others. The participants confidence to resist the urge to use alcohol or other 
drugs in these situations is measured on a 6-point scale from 0 ‘not at all confident’ 
to 100 ‘very confident’. A mean score is computed (range=0 to 100), whereby 
higher scores are indicative of greater confidence to resist urges to use substances. 
The DTCQ-8 has proven high internal consistency in 
evaluating treatment outcomes among those with alcohol 
and other drug problems (Cronbach’s α=0.98; Sklar, Annis, 
& Turner, 1997; Sklar & Turner, 1999), and was also 
shown to be highly reliable in the current study among 
forensic inpatients (Cronbach’s α=0.91). 
Drug Related 
Locus of Control 
(DR-LOC; Ersche 
et al., 2012) 
The 15-item DR-LOC assesses the extent to which a person believes that the 
outcome of an event is under their personal control (i.e., internal locus of control) or 
the influence of external circumstances (i.e., external locus of control). Individual 
items are binary scored as either 0 ‘internal’ or 1 ‘external’. Items 1, 3, 5, 8, 11, 14 
and 15 are reverse coded and then all items are summed. Scores range from 0 to 15; 
higher scores indicating a stronger belief of external locus of control. 
The DR-LOC has demonstrated high internal consistency 
among clients engaged with both residential and outpatient 
drug treatment services (Cronbach’s α=0.81; Hall, 2001), 







Levenson MD-LOC (Levenson, 1973) is a 24-item self-report questionnaire 
consisting of three subscales of eight items each: internal (control over own life), 
powerful others (other’s control over one’s life) and chance (life is a matter of 
chance). Responses are scored on a 6-point Likert scale ranging from -3 ‘strongly 
disagree‘ to +3 ‘strongly agree’. A higher rating on internal locus of control 
subscale (MD-LOC Internal) indicates a strong internal locus of control, and high 
scores on the powerful others (MD-LOC Powerful Others) and chance (MD-LOC 
Chance) subscales indicates a strong external locus of control. Participants receive 
three subscale scores and it is possible to score high or low on all three dimensions 
(Kourmousi, Xythali, & Koutras, 2015). 
The internal consistency of the measure has been shown in 
mental health hospital inpatients (Cronbach’s α=0.67 for 
MD-LOC Internal, 0.82 for MD-LOC Powerful Others and 
0.79 for MD-LOC Chance; Levenson, 1973), as well as in 
the current study of forensic inpatients (Cronbach’s α=.83, 
α=.85  and α=.67 for the MD-LOC Internal, Powerful 
Others and Chance subscales, respectively). While the 
internality subscale score showed relatively low levels of 
internal consistency (Cronbach’s alpha <0.7), the MD-LOC 
items sample a wide variety of different situations and as 





et al., 1993) 
The 20 items focus on self-efficacy, self-confidence to stop using substances, and 
self-blaming thoughts. Items are rated on a 7-point Likert scale, scored from 1 
‘strongly disagree’ to 7 ‘strongly agree’ (range=20 to 140), with higher scores 
indicating more maladaptive beliefs. 
The BSU has been found to have good internal consistency 
for alcohol dependent patients (Cronbach’s α=0.91; Aslan, 
Türkçapar, Eser, & Uğurlu, 2012), and mentally ill 






To gain an understanding of the demographic and clinical characteristics of the 
participants, informed consent was obtained from almost all participants (97.4%; n=39) to 
collect existing data from participant medical files stored at the hospital. This included 
sociodemographic and clinical information such as date of birth, gender, participants, legal 
status, unlawful act, history of substance use, history of attending psychoeducational 
substance use treatment programmes in the forensic hospital, treatment history and diagnostic 
information on all serious mental disorders including schizophrenia, paranoid schizophrenia, 
schizoaffective disorder, substance use disorders, personality disorders and mood disorders.  
Statistical analysis 
Descriptive statistics were reported for outcomes relating to sociodemographic 
characteristics, feasibility, acceptability and preliminary efficacy. Inferential statistics were 
carried out to examine pre- and post-intervention comparisons. Data analyses were conducted 
using SPSS version 24, with significance levels set at p<.05 (95% confidence intervals [CI]). 
Both parametric (T-tests) and non-parametric tests (Wilcoxon Signed Ranks Test) were 
carried out, dependent upon the distribution of the data. Effect sizes were calculated and are 
reported as Cohen’s d for normally distributed data, with values indicating a small (d=0.2), 
medium (d=0.5) or large (d=0.8) effect sizes (Cohen, 2013), or r for skewed data, with values 
indicating a small (r=0.1), medium (r=0.3) or large (r=0.5) effect sizes (Fritz, Morris, & 
Richler, 2012). A thematic analysis of the qualitative data on treatment acceptability was 
performed using NVivo version 12 data analysis software. Data was coded and collated under 






Sample characteristics  
Table III displays the sociodemographic and substance use characteristics of the 
sample at baseline (n=39). Thirty-two participants were male (82.1%) and seven were female 
(17.9%).   
 





















Sociodemographic, mental health, substance use and substance use treatment characteristics of the 
sample (n=39) 
 
Characteristic  Statistic 
Male gender, % (n) 82.1 (32) 
Age, M (SD)  41.7 (11.09) 
Australian born, % (n)  87.2 (34) 
Aboriginal and Torres Strait Islander, % (n) 12.8 (5) 
Primary mental health diagnosis  
Schizophrenia, % (n) 69.2 (27) 
Schizoaffective disorder, % (n) 20.5 (8) 
Other1, % (n) 10.3 (4) 
Legal Status   
Forensic (NGMI), % (n) 92.3 (36) 
Limiting term, % (n) 5.1 (2) 
 Unfit to plead, % (n) 2.6 (1) 
Unlawful Act resulting in admission to Forensic Hospital   
Murder, % (n) 43.6 (17) 
Grievous bodily harm, % (n) 25.6 (10) 
Assault, % (n) 10.3 (4) 
Robbery, % (n) 7.7 (3) 
Arson, % (n) 5.1 (2) 
Sexual offences, % (n) 5.1 (2) 
Other2, % (n) 20.6 (10) 
Age of first alcohol/drug use, M (SD) 14.0 (3.2) 
First drug used (n=37)  
 Alcohol, % (n)  86.5 (32) 
 Cannabis, % (n) 5.4 (2) 
 Benzodiazepines, % (n)  2.7 (1) 
 Meth/amphetamines, % (n) 2.7 (1) 
            Heroin, % (n) 2.7 (1) 
Most recent use of alcohol or drug (n=38)  
            In current forensic hospital placement, % (n) 7.9 (3) 
 In custodial placement, % (n)  18.4 (7) 
 In the community, % (n) 73.7 (28) 
Type of substance most recently used (n=38)  
 Alcohol, % (n)  47.4 (18) 
 Cannabis, % (n) 36.8 (14) 
 Ecstasy, % (n) 7.9 (3) 
 Meth/amphetamines, % (n) 36.8 (14) 
 Heroin, % (n) 5.3 (2) 
 Other opiates, % (n) 2.6 (1) 
Main current drug of concern (n=38)  
 Alcohol, % (n)  39.5 (15) 
 Cannabis, % (n) 26.3 (10) 
 Meth/amphetamines, % (n) 26.3 (10) 
 Heroin, % (n) 5.3 (2) 
 Other opiates, % (n) 2.6 (1) 
Ever sought treatment from a health professional or service for alcohol 
or other drug use (n=37) 
43.2 (16) 
Age first sought treatment from a health professional or service3, M (SD) 22.8 (5.6) 
First type of treatment sought 3  





 Inpatient mental health unit, % (n) 12.5 (2) 
 Outpatient counselling, % (n) 6.3 (1) 
 Methadone/buprenorphine maintenance, % (n) 6.3 (1) 
 Community mental health team, % (n) 6.3 (1) 
 Current Forensic Hospital placement, % (n)  6.3 (1) 
 Custodial health services, % (n)  6.3 (1) 
 Community health programme, % (n)  6.3 (1) 
 Alcoholics/narcotics anonymous, % (n) 6.3 (1) 
Previously participated in the ‘psychoeducational addressing substance 
use’ group in the forensic hospital (n=39), % (n)  
 
61.5 (24) 
1 Bi-polar disorder or automatism,  
2  Attempted murder, dangerous driving occasioning death, soliciting to commit murder 









Participant adherence to the treatment programme was high, with 97.4% (n=38) 
attending at least one session and 61.5% (n=24) attending all 12 sessions. The median 
number of sessions attended was 12 (range=0-12). Reasons for non-attendance at sessions 
varied. The principal reason was patient refusal (62.0%), followed by patients being 
discharged from hospital (24.1%), appointment conflicts (8.6%) and being unable to go 
outside to attend the group because of poor air quality due to the NSW bushfires and 
associated health conditions accounted (5.2%).  
The follow-up rate was also high, with 84.6% (n=33) participating in the post-
intervention assessments. In relation to treatment motivation, participants scored an average 
of M=24.54 (SD=5.19) on the identified motivation subscale of the TEQ-9, M=11.59 
(SD=5.34) on the introjected subscale and M=11.10 (SD=5.90) on the external subscale. This 
indicates the participants were primarily motivated to enter treatment by the value of positive 
behaviour change and less motivated by the potential negative consequences of not changing 
or other external pressures.  
Acceptability  
Mean scores on the CSQ-8 at post-intervention were M=28.6 (SD=3.57), indicating 
high levels of satisfaction with the programme. Two-thirds (63.6%) of participants reported 
that they were generally “very satisfied” with the service they received, while the remaining 
third (33.3%) reported themselves as being “mostly satisfied”. Just over half (54.5%) 
reported that the service “helped a great deal” with their problem, while 45.5% stated it 
“helped somewhat”.  
The mean score for the WAI-SF was M=69.13 (SD=7.43). One-third (33.3%) 





48.5% reporting they “always” felt this. Over half (57.6%) reported feeling that they and the 
facilitator “always” had mutually agreed upon goals with one-third (30.3%) reporting that 
they “very often” had mutual goals. Table IV reports the qualitative data pertaining to 
positive and negative feedback on the programme, grouped into six specific themes relating 
to satisfaction with SUTP.  
 







Qualitative findings relating to satisfaction with SUTP 
Positive aspects of SUTP  
Theme 1: Visual 
impact of group 
sessions 
“They didn’t just sit there and tell us like ‘bang, bang, bang, yeah, yeah, 
yeah’, they actually showed us” 
“It was quite good the realisation of how much money you actually spend 
where, you know, how when you look at that total, you think ‘oh, you 
could’ve bought this, you could’ve bought this, you could’ve had this’. That 
was a bit of a wakeup call” 
Theme 2: Craving, 
coping, triggers 
“Triggers, it dealt with triggers really well and everybody, most people in 
the group, were really honest about triggers, so yes, I like how it dealt with 
triggers” 
“And the coping strategies so who you feel comfortable talking to and 
bringing it up with and stuff like that. Like a network of family, friends and 
social groups and all that stuff, and what to do if you are craving or how 
not to get yourself in that situation in the first place” 
Theme 3: Feeling 
supported, connected 
and understood 
“I didn’t feel so alone in my journey” 
“I know that I’m not the only one like that” 
Theme 4: Learning 
from others 
“Learning from other people’s mistakes in the group, the girls opening up 
about their addictions, and myself as well”.  
“In other groups you had to read and write a lot more, but this group I felt 
taught me more by listening and by talking” 
Negative aspects of SUTP 
Theme 1: Substance 
use discussion 
generates cravings 
“Suppose concentrating on hearing other people’s shares; if you like on 
their drug and alcohol use, sometimes it made you crave for it”  
“Yeah, it made you think about it after group. You might think about it like 
‘aw, you know, gee, I wouldn’t mind a drink’ and someone was saying they 
‘ah yeah, wanted a drink’, and you start thinking ‘yeah I wouldn’t mind a 
drink’”. 
Theme 2: Irritation 
with other group 
participants 
“All the things so people talk over other people and some of them they are 
very proud about their history. I don’t like it” 
“We set up the rules before the group start, about not talk over people. It’s 








Table V outlines the baseline and post-intervention scores, p-values and effect sizes 
for each of the outcome measures. A paired-samples t-test was conducted to compare 
participant drug-taking confidence ratings, using the DTCQ-8. Mean scores on DTCQ-8 
increased from baseline (M=75.98) to post-intervention (M=80.97), however, this difference 
was not statistically significant (t(29)=-.923, p=.364). This indicates that the SUTP did not 
produce statistically significant improvements in participants’ confidence to resist substances 
in future high-risk situations.  
 














Baseline and post-intervention scores, p-values and effects sizes for each outcome variable 
Measure Baseline Post -intervention  p-value  Effect size 
DTCQ-8, M (SD; n)  75.98 (23.29; 39) 80.97 (17.52; 31) .364  d = 0.24 
DR-LOC, Mdn (Range; n)   1.13 (1.00- 1.53; 37) 1.07 (1.00-1.27; 31) <.001  r = 0.67 
MD-LOC Internal, Mdn (Range; n) 11.00 (0.00-32.00; 38) 40.00 (17.00-48.00; 31) <.001 r = 0.86 
MD-LOC Chance, M (SD; n)   23.68 (11.33; 38) 24.07 (10.41; 31) .745  d = 0.04 
MD-LOC Powerful Others, M (SD; n)   22.94 (12.38; 35) 24.19 (11.74; 31) .648  d = 0.10 





A Wilcoxon Signed Ranks test revealed that participant scores on the DR-LOC 
reduced significantly from baseline (Mdn=1.13) to follow-up (Mdn=1.07; Z=-3.66, p<.001), 
indicating a significant increase in levels of drug-related internal locus of control over this 
period. A Wilcoxon Signed Ranks test and two paired-samples t-tests were conducted to 
compare participant locus of control for the MDLOC subscales of Internal, Chance, and 
Powerful Others, respectively. Scores on the MD-LOC Internal subscale increased 
significantly from baseline (Mdn=11.00) to post-intervention (Mdn=40.00; Z=-4.81, p<.001), 
indicating an increase in the level to which participants felt in control of their situation. No 
significant differences were detected in means scores between baseline and post-intervention 
for the MD-LOC Powerful Others (t(29)=-3.28, p=.745) or the MD-LOC Chance (t(29)=-
.461, p=.648) subscales.   
A Wilcoxon Signed Ranks test showed that while participant beliefs about substance 
use on the BSU decreased from baseline (Mdn=42.00) to post-intervention (Mdn=34.00), 
these changes were not significant (Z=-.407, p=.684), indicating that there were no significant 






This study builds on previous work conducted in the UK evaluating the SUTP for 
mentally ill offenders and demonstrates the feasibility, acceptability and preliminary efficacy 
of this programme in the Australian forensic setting. The high levels of adherence to 
treatment sessions and retention in the study to post-intervention shows that the 12-week 
group programme is feasible to run in a high secure forensic environment, which often has a 
number of competing daily priorities. The SUTP also demonstrated that it is an acceptable 
treatment program for this setting, as evidenced by its high satisfaction ratings and strong 
therapeutic alliance between facilitators and patients. Importantly, the programme 
demonstrated efficacy in increasing locus of control and beliefs. This is the first international 
adaptation of the SUTP and the first time a CBT-based substance use treatment programme 
has been trialed among mentally ill prisoners in a high secure setting in Australia. These 
positive findings indicate the programmes suitability for this population and the utility of 
adapting the program to the Australian high secure setting by consulting experts with a lived 
experience of mental illness and from the Australian indigenous community. 
The sociodemographic characteristics of this sample were similar to those in previous 
reports of NSW forensic inpatients (JHFMHN, 2016), indicating the sample was generally 
representative of forensic inpatients in this setting. The number of Australian-born 
participants in this study (87.2%) was slightly higher than that of the general population when 
last surveyed (71.5%; Australian Bureau of Statistics, 2017). This could be attributed to lower 
levels of English among individuals born outside of Australia, excluding them from 
participating in SUTP. The Aboriginal and Torres Strait Islander representation in the sample 
was slightly below the average reported in NSW forensic mental health inpatient settings 
(12.8% vs. 16.8%; JHFMHN, 2016), which is possibly due to the increased prevalence of 





incarcerated (Shepherd, 2017), potentially limiting their eligibility for referral. Prevalence of 
mental health diagnoses of the sample was in line with recent reports (Miles, 2015), with 
69.2% of the sample having a primary diagnosis of schizophrenia. Almost half of participants 
(43.6%) reported murder as the unlawful act resulting in admission to the forensic hospital. 
Participants in the programme had a history of substance use, however, the vast majority had 
not used drugs or alcohol since their placement in the forensic hospital (92.1%). Almost half 
of participants (45.9%) had sought treatment from a health professional for substance use 
issues and approximately two-thirds (61.5%) had been referred to (and attended) the 
‘psychoeducational addressing substance use’ group in the hospital previously.  
Feasibility 
The forensic mental health population are notoriously difficult to engage in substance 
related treatment programmes (McMurran, 2002; Miles, 2015). However, the high levels of 
adherence (i.e., attendance at sessions) reported in the current study demonstrate the 
feasibility of the programme for this group. Understandably, some treatment attrition 
occurred, which is typical of this environment due to some patient non-engagement in 
treatment programmes, particularly among patients who have been recently admitted and are 
at an earlier stage of the rehabilitation process. While attrition has been reported as a 
significant challenge in the treatment of female mentally ill offenders specifically (Long, 
Fulton, Fitzgerald, & Hollin, 2010), no attrition occurred in the female sample in the current 
pilot study. This is a positive indicator of feasibility, when considering its future 
implementation among female patients in the current treatment service.  
Acceptability  
There were high levels of satisfaction reported by the participants on the CSQ-8, and 
the majority (96.9%) reported feeling “very” or “mostly” satisfied with SUTP as a treatment 





programmes in custodial settings (Barrett, Indig, Sunjic, Sannibale, Sindicich, Rosenfeld, 
Najavits, & Mills, 2015), the SUTP demonstrated high levels of satisfaction. The quantitative 
findings of high acceptability are reinforced by the positive qualitative data collected in the 
semi-structured interviews. For example, one participant reported “I felt I was included and 
listened to and the peers were really good supportive and helpful. It was a good group”. 
These findings are important as high levels of client satisfaction are often positively 
associated with improved treatment outcomes for patients in substance use programmes 
(Boden & Moos, 2009; Carlson & Gabriel, 2001). Moreover, treatment programmes have a 
better chance of longer-term successful implementation when patient groups record high 
levels of satisfaction (Andersson, Otterholt, & Gråwe, 2017). The therapeutic alliance ratings 
were moderate when compared with similar substance use rehabilitation treatment 
programmes for offenders (Dekker, 2010). Moderate scoring in therapeutic alliance in an 
involuntary secure setting is interpreted as positive, especially given the challenges posed in 
overcoming power imbalances in these environments. Therapeutic alliance in the current 
study could have been impacted by the difficulty of operating a 12-week programme, where 
programme facilitators are occasionally absent due to sickness and other role priorities such 
as mental health review tribunals. Staff were often in the position where they substituted for 
each other, which naturally inhibits a strong patient facilitator relationship from growing. 
This could potentially be managed better if the programme is fully integrated into the service 
in the future, as groups could be postponed until the following week when the facilitators 
were available. Unfortunately, due to the restricted timeline and manualised research protocol 
for the current pilot trial, there was no opportunity to do this, and staff had to exercise a 





Preliminary Efficacy  
In relation to efficacy of the SUTP program, there were statistically significant 
improvements in drug related locus of control and internal locus of control. Participants felt 
more in control of their drug use and took on a much larger sense of responsibility 
surrounding it, following their participation in the treatment programme. This is a positive 
finding, and if sustained over the course of their time in the forensic hospital, would place 
them in a better position to rehabilitate through the hospital and maintain sobriety in the 
community. It should be noted that the internal consistency of this measure was α=0.66 in 
this study, which indicates the outcome should be interpreted with a cautious optimism. In 
many forensic settings around the world, patients move through levels of security based upon 
risk assessments completed by their multi-disciplinary treating teams. Drug and alcohol use is 
specifically considered within these assessments, so patients who demonstrate increased 
insight and confidence in relation to their ability to control their substance using behaviours 
are likely to be assessed as lower risk. This could mean transitioning through the hospital at a 
quicker pace, dependent on other factors and potentially being cared for in less restrictive 
environments, such as low and medium secure settings. Due to their environment patients 
don’t have physical temptations to use alcohol or drugs, when transferred to a less secure unit 
or into the community the availability of illicit substances increases (Dolan & Kirwan, 2001). 
A stronger-drug related internal locus of control may place them in a better position to 
prevent relapse and ultimately readmission to forensic secure services. This would ultimately 
have positive consequences for society, with lower recidivism rates due to less substance-
related criminal activity.  
Given the restrictive environment of forensic hospitals, it is not possible to measure 
substance use-related behavioural changes. Rather, in these settings, it is considered 





which is indicative of their future behaviours. No significant differences were found in 
participants beliefs about substance use or their confidence to resist substance use in the 
future. Miles (2015) demonstrated significant improvements in beliefs about substance use 
from baseline to 6-month follow-up, which was possibly due to the inclusion of booster 
sessions that may have significantly contributed to the change in beliefs. Unlike Miles 
(2015), booster sessions were not offered in this pilot study. Participants demonstrated high 
levels of confidence in their ability to refuse substances at baseline, so the small size of 
confidence improvement could be due to their forced abstinence environment which can 
provide a ‘false’ confidence due to not being exposed to temptation to use in many years.   
This study has a number of strengths including the recruitment of a suitable pilot 
sample size, high post-intervention follow-up rates and the completion of assessments by an 
individual independent of the treating team. Despite these strengths, there are a number of 
limitations in this study. Firstly, while the sample size was suitable for the purposes of the 
current study and is consistent with other studies in forensic hospitals worldwide (Miles, 
2015; Morris & Moore, 2009; Ritchie et al., 2011) it is too small to form any strong 
conclusions regarding efficacy. It may also be the reason some significant results weren’t 
detected. There is also no control group to compare participant outcomes to, and as such, a 
randomised controlled trial of the SUTP with a larger sample of mentally ill offenders is 
required in order to rigorously examine efficacy of this intervention. The effect sizes reported 
here are intended to guide such future investigations. Although it is known which participants 
had previously attended the psychoeducational substance use group, no data was collected on 
other groups attended prior to commencement of the SUTP, including those that are not 
aimed at substance use but which use CBT to build insight into their mental illness and 
offending behaviour. It is possible that some patients would have gained skills in these pre-





have contributed to the positive findings of this study. Future studies would benefit from 
controlling for previous or other concurrent treatments in their analysis. Finally, no longer-
term follow up was completed with the participant group to determine if treatment effects 
would remain over a longer period of time. This is important in the context of SUTP as 
previous work in this area showed significant changes in beliefs about substance use at post-
treatment (Beck et al., 1993) which were later found to be not significant at 6-month follow 
up (Miles, 2015). In conducting any longitudinal study, consideration of the impact of patient 
transfer to medium- and low-secure services, as well as to the community, will have to be 
made. Intensive and rigorous follow-up in these settings would be required.  
Collectively, this study contributes further evidence that SUTP is an efficacious 
programme that is deemed as acceptable by patients and is highly feasible in forensic secure 
services. Given this is the first study outside the UK and the findings are positive, it provides 
optimism that SUTP could be implemented in forensic services across Australia. This will 
address substance use among mentally ill offenders, a common and harmful comorbidity 
which contributes to poorer clinical outcomes and increased risk of recidivism for patients 
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